Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beinaglutide vs Dulaglutide in T2D with Overweight or Obesity
NCT05005741Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of beinaglutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
beinaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT05005741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005741.